Crossmark

Single cell dissection of plasma cell heterogeneity in symptomatic and asymptomatic myeloma

Crossref DOI link: https://doi.org/10.1038/s41591-018-0269-2

Published Online: 2018-12-06

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ledergor, Guy

Weiner, Assaf

Zada, Mor

Wang, Shuang-Yin

Cohen, Yael C.

Gatt, Moshe E.

Snir, Nimrod

Magen, Hila

Koren-Michowitz, Maya

Herzog-Tzarfati, Katrin

Keren-Shaul, Hadas

Bornstein, Chamutal

Rotkopf, Ron

Yofe, Ido

David, Eyal

Yellapantula, Venkata

Kay, Sigalit

Salai, Moshe

Ben Yehuda, Dina

Nagler, Arnon

Shvidel, Lev

Orr-Urtreger, Avi

Halpern, Keren Bahar

Itzkovitz, Shalev

Landgren, Ola

San-Miguel, Jesus

Paiva, Bruno

Keats, Jonathan J.

Papaemmanuil, Elli

Avivi, Irit

Barbash, Gabriel I.

Tanay, Amos

Amit, Ido https://orcid.org/0000-0002-5880-2845
License Information

Text and Data Mining valid from 2018-12-01
More Information

Article History

Received: 6 July 2018

Accepted: 29 October 2018

First Online: 6 December 2018

Competing interests

: The authors declare the following competing interests: a patent application (US Provisional Patent Application No. 62/756,640) has been filed related to this work. O.L. declares receiving funding and/or honoraria from Adaptive, Amgen, Binding Site, BMS, Celgene, Cellectis, Glenmark, Janssen, Karyopharm, Pfizer, Seattle Genetics and Takeda.